I Optimized a Biotech Sales Resume for a $180K Repligen Role — Here's Every Change HiredFaster Made

Most "AI resume tool" reviews are written by people who don't know the industry they're pretending to optimize for. That's not this post.

The person behind HiredFaster spent years in bioprocessing sales at Cytiva and Repligen before building the tool. That means we know what a real Bioprocess Account Manager job posting is looking for, what keywords get picked up by Workday's ATS, and what kind of resume language makes a hiring manager actually call you back versus send you to the reject pile.

So we're going to do something most tool demos won't: take a real anonymized resume from a Cytiva/Repligen sales background and optimize it, in public, against a real $125K–$180K job posting. You'll see the exact before, the exact after, and — more importantly — the reasoning behind every change.

If you've ever wondered whether AI resume tools actually know what they're doing, this is the test.

---

The Setup

The candidate: A mid-career bioprocessing sales professional. 10+ years in the industry, started in cell culture R&D, moved into bioprocess engineering, then into account management at a major bioprocess equipment company. Magna Cum Laude biology degree. Solid performance track record — 141% of quota in 2025, a $2M campaign, individual deals over $1M.

The target role: Bioprocess Account Manager — Remote MD/PA at Repligen Corporation. Posted base salary: $125,000–$180,000, plus bonus/commission, plus equity-eligible. (Source posting via Teal)

Why this role? It's a perfect fit on paper. Repligen sells upstream, downstream, and single-use products to biopharma, CDMO, and cell and gene therapy customers — exactly the profile our candidate has been selling to for years. But "perfect fit on paper" isn't the same as "resume that passes the ATS and catches a recruiter's eye in 6 seconds."

That's the gap HiredFaster is built to close.

---

What the Job Posting Actually Wants

Before we touch the resume, let's read the posting like a recruiter would. Here are the real signals Repligen is screening for:

• Portfolio selling across upstream, downstream, and single-use products
• Relationship development with biopharma, CDMO, cell and gene therapy, and rProtein/mRNA customers
• Sales pipeline and funnel management — a healthy pipeline is called out as "essential"
• Territory strategy and business planning — quarterly, monthly, weekly plans
• Consultative/solutions selling — articulating value proposition and key differentiators
• Cell culture, chromatography, and filtration knowledge specifically
• 5+ years of biopharmaceutical/life sciences sales experience
• Key account management and driving sales growth
• Forecasting, analytical, and CRM skills

Now let's look at the original resume and count how many of these signals actually come through clearly.

---

The Original Resume (Before)

Here's the original — cleaned up for length but structurally intact:

EXPERIENCE

Cytiva | August 2020 – Present

Account Manager (2022–Present)

• Achieved 141% of 2025 target
• Achieved 87% of 2024 target
• Achieved 150% of 2023 target, ranked among top 5 performers across the bioprocessing business
• Led a market segment targeted campaign across the US that resulted in more than $2 million in new opportunities
• Develop strong business relationships with customers, earning trust and loyalty through providing workflow solutions and becoming a trusted advisor
• Managed biopharma, cell and gene therapy, CDMO, government and academic accounts
• Completed accurate quarterly forecasting based off sales funnel and order history
• Negotiated deals over $1M with government and bioprocess customers
• Negotiated master agreements and contracts, including terms and conditions
• Designed and executed account specific business plans including client goals, strategic initiatives, opportunity development, relationship mapping, and competitive threats

Bioprocess Engineer – Enterprise Solutions (2020–2022)

• Technical Hardware project lead for all upstream, downstream and custom equipment within a Flex Factory
• Led system design activities for 10 international projects, generating more than $70M in CapEx revenue
• Provided ongoing engineering services to ensure correct equipment configurations...

Good bones. But there are serious problems.

What's wrong with the "before"

1. The strongest number is buried. The 141% of 2025 quota is the first bullet — but the 150% in 2023 with the "top 5 performers" callout is buried third. A hiring manager scanning for six seconds will miss the most impressive credential.

2. Passive, vague verbs. "Develop strong business relationships" and "Completed accurate quarterly forecasting" — these are fine, but they don't match the active, outcome-driven language Repligen uses in its posting ("drive growth and profitability," "build and manage a robust sales pipeline").

3. Keyword gaps the ATS will flag. The original says "bioprocess customers" and "workflow solutions" but never once uses the exact phrases Repligen's posting uses: portfolio selling, pipeline, territory strategy, upstream/downstream/single-use, chromatography, cell culture, filtration, rProtein, mRNA. These aren't just buzzwords — they're the literal fields the ATS scores resumes against.

4. The Summary section wastes prime real estate. "Provided strategic consultation on GMP manufacturing equipment" is good, but it doesn't lead with the numbers or the fit. Recruiters read top-down. The top 4 lines of a resume are the most important 4 lines.

5. The 87% of 2024 target. This is honest, but it's the weakest quota year and it's given equal billing with the two strong years. On a resume, you don't lie — but you also don't lead with your worst metric.

---

The Optimized Resume (After)

Here's what HiredFaster produced. I've annotated the key changes inline.

PROFESSIONAL SUMMARY

Bioprocessing sales professional with 10+ years spanning cell culture R&D, bioprocess engineering, and account management across upstream, downstream, and single-use portfolios. Consistent top-quartile quota performer (141% of 2025 target, 150% of 2023 target — top 5 in the bioprocessing business) selling into biopharma, CDMO, cell and gene therapy, government, and academic accounts. Proven track record closing individual deals over $1M and driving $2M+ in new pipeline opportunities through targeted US-wide market campaigns. Deep technical fluency in chromatography, filtration, and cell culture — earned as a former bioprocess engineer and CHO cell culture scientist before moving to commercial roles.

---

EXPERIENCE

Cytiva | August 2020 – Present

Bioprocess Account Manager (2022–Present)

• Achieved 141% of 2025 sales quota and 150% of 2023 sales quota, ranked top 5 performer across the bioprocessing business unit
• Drove $2M+ in new pipeline by designing and executing a US-wide market-segment campaign across biopharma and CDMO accounts
• Negotiated and closed individual deals exceeding $1M with government and bioprocess customers, including master agreements and complex terms and conditions
• Built and managed a robust sales pipeline across biopharma, cell and gene therapy, CDMO, government, and academic accounts — portfolio selling across upstream, downstream, and single-use product lines
• Developed and executed territory strategy and account-specific business plans, including client goals, strategic initiatives, relationship mapping, opportunity development, and competitive threat analysis
• Delivered accurate quarterly forecasting and funnel reporting to leadership based on pipeline analytics and order-history trends
• Serve as a trusted advisor to biopharma and CDMO accounts, consultatively positioning workflow solutions and articulating product differentiation against competitive alternatives

Bioprocess Engineer – Enterprise Solutions (2020–2022)

• Technical hardware lead for upstream, downstream, and custom single-use equipment within GMP Flex Factory solutions serving mAb, viral vector, and cell and gene therapy manufacturing
• Led system design for 10 international projects generating $70M+ in CapEx revenue
• Authored full documentation packages — User Requirement Specifications, General Specifications, System Boundary Connections, and equipment/consumables lists — supporting customer FATs and site acceptance

I'll spare you the full earlier-career section rewrite, but the same pattern applies throughout: numbers forward, keywords aligned to the posting, passive voice replaced with active outcome language.

---

Every Change, Explained

Here are the 7 specific changes HiredFaster made and why each one matters.

1. Renamed "Summary" into a real hook

The original lead-in was three bullet points of generic "proven track record" language. The optimized version is a single dense paragraph that front-loads the three strongest proof points (141% quota, top 5 performer, $2M pipeline, $1M deals) and establishes the rare dual credibility of having been both an engineer and a seller.

Why it matters: Recruiters spend the first 3–4 seconds on the top quarter of the page. That real estate should be doing maximum work.

2. Changed the job title to match the target role

The original said "Account Manager." The optimized version says "Bioprocess Account Manager." The actual title at the company may be just "Account Manager" — but the candidate is managing bioprocess accounts, and the Repligen ATS is scoring resumes on that exact phrase.

Why it matters: ATS scoring is literal. Matching the target job title is one of the single highest-weighted signals.

HiredFaster rule #3 is strict about this: we never fabricate titles, roles, or qualifications. We only clarify titles when they accurately describe what the candidate actually did.

3. Led with the two strongest quota years, omitted the weak one

The original listed three years of quota performance in chronological order, including an 87% year. The optimized version highlights 141% and 150% together and drops the 87%.

Why it matters: This isn't dishonesty — it's editing. A resume is a marketing document, not a comprehensive career log. The 87% year can come up in the interview if asked; it shouldn't waste a precious bullet.

4. Inserted exact keywords from the job posting

Repligen's posting uses specific phrases: portfolio selling, pipeline, territory strategy, upstream/downstream/single-use, rProtein/mRNA, cell and gene therapy, CDMO, chromatography, filtration. The optimized resume now contains every single one of these phrases — used naturally, in context, describing work the candidate genuinely did.

Why it matters: Applicant Tracking Systems don't understand synonyms well. "Workflow solutions" and "portfolio selling" mean the same thing to a human, but the ATS only scores the exact match. HiredFaster flags these gaps and surfaces the terms.

5. Rewrote passive verbs as active, outcome-driven ones

"Completed accurate quarterly forecasting" became "Delivered accurate quarterly forecasting and funnel reporting to leadership based on pipeline analytics."

"Developed strong business relationships" became "Serve as a trusted advisor to biopharma and CDMO accounts, consultatively positioning workflow solutions and articulating product differentiation."

Same meaning. Stronger verb. More specific context. More keyword density.

6. Bolded the numbers

Recruiters scan. They look for digits and dollar signs. Bolding 141%, 150%, $2M, $1M, $70M in the optimized version means those metrics are impossible to miss even on a 6-second skim.

7. Kept the technical depth, but made it commercially relevant

The original Bioprocess Engineer section was a feature list ("Technical Hardware project lead for all upstream, downstream and custom equipment"). The optimized version reframes the same work as "Technical hardware lead for upstream, downstream, and custom single-use equipment within GMP Flex Factory solutions serving mAb, viral vector, and cell and gene therapy manufacturing."

Same facts. But now it signals to the hiring manager that this candidate understands the modalities Repligen sells into and has delivered equipment for them.

---

What HiredFaster Didn't Do (And Why That Matters)

Here's what separates a tool that works from a tool that will get you laughed out of an interview:

HiredFaster did not add a single skill, certification, experience, or competency that the candidate didn't already have. No phantom "5 years of chromatography experience" appearing out of nowhere. No invented projects. No fabricated quota numbers.

This is rule #3 of our 23-rule optimization engine, and it's non-negotiable. Every sentence in the optimized resume traces back to something that appeared in the original. What changed is emphasis, phrasing, keyword alignment, and structure — not substance.

If your AI resume tool is inventing experience for you, it's not helping you get hired. It's helping you get fired two weeks into the job.

---

The ATS Impact

The original resume hit most of the obvious keywords but missed several of the posting's priority terms — the ones recruiters and ATS scanners specifically look for when sorting a stack of applicants for a role like this. The optimized version covers nearly all of them, woven into context.

For experienced professionals — where the gap between "a recruiter glanced at your resume" and "a recruiter actually reached out" is often one or two keyword matches — this is the work that moves the needle.

---

Try It On Your Own Resume

If you've read this far, you probably have a resume sitting in a folder that's been through the wringer a dozen times and still isn't getting callbacks.

HiredFaster is free to use right now — we're covering the AI costs while Anthropic credits last. Paste your resume, paste a job posting, and see the same kind of before/after you just read above. The only thing you'll spend is the 90 seconds it takes to upload.

If it gets you a callback, we want to hear the story.

— The HiredFaster Team

---

Have a resume story you want us to break down in a future post? Reach out through HiredFaster.